Electrospun nanofibrous membranes and disposable glucose biosensor
US-9708640-B2 · Jul 18, 2017 · US
US10316284B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10316284-B2 |
| Application number | US-201515126236-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 23, 2015 |
| Priority date | Mar 25, 2014 |
| Publication date | Jun 11, 2019 |
| Grant date | Jun 11, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention concerns a bioreactor obtained by compressing a mixture of an enzyme, a conductor and chitosan. The conductor can consist of carbon nanotubes. This bioreactor can be produced according to the following steps: preparing a mixture of powders in which the proportion of enzyme powder relative to a carbon nanotube powder is of the order of 50/50 by weight; preparing a viscous solution of chitosan in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% by volume in water; adding the viscous chitosan to the mixture of powders in a proportion be weight of 3 to 5 of powder to 5 to 10 of chitosan; carrying out a first compression followed by light grinding; carrying out a second compression to produce a pellet; and drying at ambient temperature.
Opening claim text (preview).
The invention claimed is: 1. A bioreactor obtained by a method comprising the steps of: preparing a mixture of an enzyme powder and a carbon nanotube powder where the proportion of enzyme powder relative to carbon nanotube powder is of the order of 50/50 by weight; preparing a viscous solution of chitosan in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% by volume in water; adding the viscous chitosan to the mixture of enzyme powder and carbon nanotube powder in a proportion by weight of 3 to 5 of this mixture to 5 to 10 of chitosan; carrying out a first compression followed by light grinding; carrying out a second compression to produce a pellet; and drying at ambient temperature. 2. The bioreactor of claim 1 , wherein the pressure applied during the first and the second compression is within a range from 2,000 to 6,000 kPa. 3. The bioreactor of claim 1 , wherein the solution comprises from 0.002 to 0.005% in mass per volume of genipin. 4. The bioreactor of claim 1 , wherein the solution comprises from 0.001 to 0.005% in mass per volume of caffeic acid. 5. The bioreactor of claim 1 , wherein a porous chitosan-based membrane is laid on an active surface of the bioreactor and bonded at the periphery thereof. 6. The bioreactor of claim 5 , wherein the porous chitosan-based membrane is obtained by a method comprising the steps of: preparing a solution in a ratio of 5 to 15 (in mg) of chitosan to 0.75 to 1.25 (in ml) of acetic acid diluted to 0.4 to 0.6% in water; stirring; pouring on a smooth support; and drying for a period from 2 to 4 days at ambient temperature. 7. The bioreactor of claim 5 , having a pellet-shaped bioelectrode, wherein a conductor is glued by means of conductive glue to the surface of the pellet-shaped bioelectrode opposite to the active surface. 8. The bioreactor of claim 5 , wherein the membrane comprises a plurality of pores having an average diameter in the range from 1 to 10 nanometers. 9. The bioreactor of claim 5 , wherein the membrane comprises a smooth surface facing the pellet-shaped electrode and a rough surface facing outwards. 10. The bioreactor of claim 7 , wherein the membrane comprises a plurality of pores having an average diameter in the range from 1 to 10 nanometers. 11. The bioreactor of claim 7 , wherein the membrane comprises a smooth surface facing the pellet-shaped electrode and a rough surface facing outwards. 12. The bioreactor of claim 2 , wherein the solution comprises from 0.002 to 0.005% in mass per volume of genipin. 13. The bioreactor of claim 2 , wherein the solution comprises from 0.001 to 0.005% in mass per volume of caffeic acid.
Pressing, rolling, calendering (membrane electrode assemblies H01M8/1004) · CPC title
Fuel cells in portable systems, e.g. mobile phone, laptop · CPC title
Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood (amperometry per se G01N27/49; aspects concerning the enzyme reagent C12Q1/001) · CPC title
Electrical apparatus, e.g. sparking plugs or parts thereof · CPC title
Organic or organo-metallic compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.